anavex.com | CNS Therapeutics | Anavex Life Sciences

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-Agent: AdsBot-Google-Mobile User-Agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/*

Meta Tags

Title	CNS Therapeutics \| Anavex Life Sciences \| New
Description	Targeting CNS Anavex Life Sciences Corp. (Nasdaq: AVXL) is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and development of targeted CNS
Keywords	N/A

Server Information

WebSite	anavex.com
Host IP	185.230.63.186
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

artistictouchdentistry.com

anavex.com Valuation

US$42,897,801

Last updated: 2022-06-21 08:11:27

anavex.com has Semrush global rank of 246,733. anavex.com has an estimated worth of US$ 42,897,801, based on its estimated Ads revenue. anavex.com receives approximately 4,949,747 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, anavex.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$42,897,801
Daily Ads Revenue	US$39,598
Monthly Ads Revenue	US$1,187,940
Yearly Ads Revenue	US$14,255,270
Daily Unique Visitors	329,984
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
anavex.com.	A	3600	IP: 185.230.63.186
anavex.com.	A	3600	IP: 185.230.63.107
anavex.com.	A	3600	IP: 185.230.63.171
anavex.com.	NS	86400	NS Record: ns6.wixdns.net.
anavex.com.	NS	86400	NS Record: ns7.wixdns.net.
anavex.com.	MX	3600	MX Record: 10 mailstore1.secureserver.net.
anavex.com.	MX	3600	MX Record: 0 smtp.secureserver.net.

HtmlToTextCheckTime:2022-06-21 08:11:27

Home About Us Therapeutic Candidates SIGMACEPTOR Our Dedication Alzheimer’s Disease Angelman Syndrome Depression Fragile X Syndrome Frontotemporal Dementia Infantile Spasms Pain Parkinson’s Disease Rett Syndrome Stroke Investors Share Data Analyst Coverage Investor Material Code of Conduct Presentations & Posters Corporate Governance Forward-Looking Statements Newsroom Press Releases Join Our Team Contact Targeting CNS Conditions utilizing genomic biomarkers to develop therapeutics for people of all ages. Welcome to Anavex Life Sciences Corp. Our SIGMACEPTOR ™ Discovery Platform produces therapeutic candidates designed to activate SIGMAR1, a novel pathway designed to target chronic central nervous system (CNS) conditions with genomic precision. Apr 7 Anavex Life Sciences to Present at the Needham Virtual Healthcare Conference Mar 28 Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit Mar 15 Anavex Life Sciences Announces Presentation of Phase 2

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 23 Oct 2021 15:48:11 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.anavex.com/
strict-transport-security: max-age=120
Age: 68953
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVisPSpdvxhEEQZ13gnr6W/r,m0j2EEknGIVUW/liY8BLLl5lGwBvY6S6kqNcXrlzUhEO5u3dMxPR3QRc6kpLZVuH,2d58ifebGbosy5xc+FRaln6RUcS1x/nCr5G2uX2FlaOF6SV2b9iy+B1Whb4/9Gh4T1c2A6dGmNLB8LYeYb+Zvg==,2UNV7KOq4oGjA5+PKsX47Br+ilU2OUaGN9cE2DqPolkfbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1635004091.872299387783225317
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 23 Oct 2021 15:48:12 GMT
content-type: text/html; charset=UTF-8
content-length: 638634
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"960a1e85b6a2565008de74e7d360e3b9"
content-language: en
strict-transport-security: max-age=120
age: 70338
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Fri, 22 Oct 2021 20:16:14 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YZZkpjMMVpZ6+DErTqZ6Qqo=,6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgLJDAhu8NTMTGQmks8KvGA,m0j2EEknGIVUW/liY8BLLvn/1fMuxpYw/Htpcq27vLUa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalvXnshbkVjAJjFnFct1D5K8HAqx2zNrDU0T6nO3dKJhfjG4oHF1VYQyXYTWNLjpHmg==,2UNV7KOq4oGjA5+PKsX47HYXd6zDG0Q4ZvIB35CKuI8fbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635004092.1082983918412130762
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e931316370ac6e5ef364ea986ac5d47131a3c8238648b9913ad1421720e4e692eff44d9d2a1b7b88e093047151c6015da372aa; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

anavex.com Whois Information

Domain Name: ANAVEX.COM
Registry Domain ID: 160779379_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-05-24T19:07:38Z
Creation Date: 2005-05-23T18:29:26Z
Registry Expiry Date: 2022-05-23T18:29:26Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS29.DOMAINCONTROL.COM
Name Server: NS30.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T02:02:00Z <<<

anavex.com valuation and analysis